BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 63 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $789,000 | -14.1% | 533,432 | +18.5% | 0.02% | -29.2% |
Q2 2022 | $918,000 | -92.1% | 450,141 | -81.1% | 0.02% | -88.3% |
Q4 2021 | $11,654,000 | -61.3% | 2,378,325 | 0.0% | 0.20% | -50.8% |
Q3 2021 | $30,086,000 | -18.2% | 2,378,325 | 0.0% | 0.42% | -29.3% |
Q2 2021 | $36,769,000 | -53.0% | 2,378,325 | 0.0% | 0.59% | -50.0% |
Q1 2021 | $78,271,000 | – | 2,378,325 | – | 1.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $29,242,000 | 11.52% |
Nan Fung Group Holdings Ltd | 1,166,952 | $18,041,000 | 5.60% |
Novo Holdings A/S | 4,503,991 | $69,632,000 | 3.09% |
Vivo Capital, LLC | 3,871,291 | $59,850,000 | 2.59% |
Sofinnova Investments, Inc. | 2,754,437 | $42,584,000 | 2.45% |
Ally Bridge Group (NY) LLC | 412,267 | $6,374,000 | 1.58% |
Samsara BioCapital, LLC | 737,459 | $11,401,000 | 1.41% |
Board of Trustees of The Leland Stanford Junior University | 719,546 | $11,125,000 | 1.04% |
RA Capital Management | 2,378,325 | $36,769,000 | 0.59% |
Rock Springs Capital Management LP | 1,619,248 | $25,034,000 | 0.50% |